Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lonafarnib

EU orphan designation number: EU/3/13/1225   
Active ingredient: Lonafarnib
Indication: Treatment of hepatitis delta virus infection
Sponsor: Eiger Biopharmaceuticals Europe Limited
30 Upper High Street, Thame, Oxon, OX9 3EZ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Centralised Orphan - Designation EMA/OD/132/13 (2014)295 of 16/01/2014